Recurrent arterial thrombosis associated with the antithrombin basel variant and elevated lipoprotein(a) plasma level in an adolescent patient

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue 4, 2012, Pages 276-279

  Szilágyi, Szabolcs ^a   Péter, Andrea ^a   Tünde Magyar, Mária ^b   Balogh, Sándor ^c   Bereczky, Zsuzsanna ^d  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Department of Neurology ^*  (Hungary)

^c National Institute for Health Development   (Hungary)

^d UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Antithrombin Basel; arterial thrombosis; Ischemic stroke; Lipoprotein(a); Myocardial infarction

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; CYTOSINE; DNA; HEPARIN; LEUCINE; LIPOPROTEIN A; PROLINE; THYMINE;

ADOLESCENT; AMINO ACID SUBSTITUTION; ARTERY THROMBOSIS; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CASE REPORT; DISEASE ASSOCIATION; DNA SEQUENCE; GENETIC VARIABILITY; HEART ATRIUM SEPTUM DEFECT; HEART INFARCTION; HETEROZYGOSITY; HUMAN; MALE; MEDICAL HISTORY; MITRAL ANNULOPLASTY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; RECURRENT DISEASE; RISK FACTOR; THROMBOGENESIS;

ADOLESCENT; ANTITHROMBIN III; BRAIN ISCHEMIA; DNA MUTATIONAL ANALYSIS; HETEROZYGOTE; HUMANS; LIPOPROTEIN(A); MALE; MUTATION; MYOCARDIAL INFARCTION; STROKE; THROMBOSIS;

EID: 84860761481     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182331ecd     Document Type: Article

References (20)

1. Mahle WT, Campbell RM, Favaloro-Sabatier J. Myocardial infarction in adolescents. J Pediatr. 2007;151:150-154. (Pubitemid 47069394)
2. Bernard TJ, Manco-Johnson MJ, Goldenberg NA. The roles of anatomic factors, thrombophilia, and antithrombotic therapies in childhood-onset arterial ischemic stroke. Thromb Res. 2011;127:6-12.
3. Vivo RP, Krim SR. ST elevation myocardial infarction in a teenager: case report and review of the literature. South Med J. 2009;102:523-526.
4. Patnaik MM, Moll S. Inherited antithrombin deficiency: a review. Haemophilia. 2008;14:1229-1239.
5. Muszbek L, Bereczky Z, Ková cs B, et al. Antithrombin deficiency and its laboratory diagnosis. Clin Chem Lab Med. 2010;48(suppl 1):S67-S78.
6. Boekholdt SM, Kramer MH. Arterial thrombosis and the role of thrombophilia. Semin Thromb Hemost. 2007;33:588-596. (Pubitemid 47429311)
7. Calcaterra D, Martin JT, Ferneini AM, et al. Acute mesenteric and aortic thrombosis associated with antithrombin deficiency: a rare occurrence. Ann Vasc Surg. 2010;24:415. e5-415. e7.
8. Peovska I, Maksimovic J, Kalpak O, et al. Recurrent myocardial infarction in a young football player with antithrombin III deficiency. Cardiol J. 2008;15:463-466.
9. Tu CM, Hsueg CH, Chu KM, et al. Simultaneous thromboses of double coronary arteries in a young male with antithrombin III deficiency. Am J Emerg Med. 2009;27:1169. e3-1169. e6.
10. Roldan V, Ordonez A, Marin F, et al. Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis. Thromb Haemost. 2009;101:483-486.
11. Chang JY, Tran TH. Antithrombin III Basel: identification of a Pro-Leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity. J Biol Chem. 1986; 261:1174-1176. (Pubitemid 16103923)
12. Kamstrup PR, Benn M, Tybjaerg-Hansen A, et al. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation. 2008;117:176-184.
13. Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302:412-423.
14. Aiach M, Gandrille S, Emmerich J. A review of mutations causing deficiencies of antithrombin, protein C and protein S. Thromb Haemost. 1995;74:81-89.
15. Chowdhury V, Lane DA, Mille B, et al. Homozygous antithrombin deficiency: report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis. Thromb Haemost. 1994;72:198-202. (Pubitemid 24251279)
16. Kamstrup PR. Lipoprotein(a) and ischemic heart disease-a causal association? A review. Atherosclerosis. 2010;211:15-23.
17. Salobir B, Sabovic M, Peternel P, et al. Fibrinolytic parameters and lipoprotein(a) in young women with myocardial infarction. Angiology. 2002;53:157-163. (Pubitemid 34263309)
18. Vormittag R, Vukovich T, Stain M, et al. Lipoprotein (a) in patients with spontaneous venous thromboembolism. Thromb Res. 2007;120:15-20. (Pubitemid 46601568)
19. Nordestgaard BG, Chapman MJ, Ray K, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;31:2844-2853.
20. Zorio E, Falco C, Arnau MA, et al. Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions. Haematologica. 2006;91:562-565.